ATE183641T1 - Verfahren zur herstellung von arzneiformen und kontrollierte freigabe und die soerhaltenen arzneiformen - Google Patents

Verfahren zur herstellung von arzneiformen und kontrollierte freigabe und die soerhaltenen arzneiformen

Info

Publication number
ATE183641T1
ATE183641T1 AT94906994T AT94906994T ATE183641T1 AT E183641 T1 ATE183641 T1 AT E183641T1 AT 94906994 T AT94906994 T AT 94906994T AT 94906994 T AT94906994 T AT 94906994T AT E183641 T1 ATE183641 T1 AT E183641T1
Authority
AT
Austria
Prior art keywords
pct
medicinal forms
controlled release
excipients
sec
Prior art date
Application number
AT94906994T
Other languages
English (en)
Inventor
Giuseppe Motta
Original Assignee
Saitec Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT000455 external-priority patent/IT1260242B/it
Priority claimed from ITBO930294A external-priority patent/IT1263445B/it
Priority claimed from IT93BO000460A external-priority patent/IT1268454B1/it
Application filed by Saitec Srl filed Critical Saitec Srl
Application granted granted Critical
Publication of ATE183641T1 publication Critical patent/ATE183641T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT94906994T 1992-12-23 1993-12-23 Verfahren zur herstellung von arzneiformen und kontrollierte freigabe und die soerhaltenen arzneiformen ATE183641T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000455 IT1260242B (it) 1992-12-23 1992-12-23 Procedimento per preparare forme farmaceutiche a rilascio controllato ritardato del principio attivo e le forme farmaceutiche cosi' ottenute.
ITBO930294A IT1263445B (it) 1993-06-24 1993-06-24 Procedimento per preparare forme farmaceutiche a rilascio controllato/ritardato del principio attivo e le forme farmaceutiche cosi' ottenute
IT93BO000460A IT1268454B1 (it) 1993-11-12 1993-11-12 Procedimento per preparare forme farmaceutiche a rilascio controllato del principio attivo e le forme farmaceutiche cosi' ottenute.

Publications (1)

Publication Number Publication Date
ATE183641T1 true ATE183641T1 (de) 1999-09-15

Family

ID=27273889

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94906994T ATE183641T1 (de) 1992-12-23 1993-12-23 Verfahren zur herstellung von arzneiformen und kontrollierte freigabe und die soerhaltenen arzneiformen

Country Status (14)

Country Link
US (1) US5662935A (de)
EP (1) EP0675710B1 (de)
JP (1) JP3459421B2 (de)
KR (1) KR100297541B1 (de)
AT (1) ATE183641T1 (de)
AU (1) AU683044B2 (de)
BR (1) BR9307736A (de)
CA (1) CA2151396C (de)
DE (1) DE69326163T2 (de)
DK (1) DK0675710T3 (de)
ES (1) ES2138070T3 (de)
GR (1) GR3031936T3 (de)
RU (1) RU2128499C1 (de)
WO (1) WO1994014421A2 (de)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5821237A (en) * 1995-06-07 1998-10-13 The Procter & Gamble Company Compositions for visually improving skin
TW487582B (en) * 1995-08-11 2002-05-21 Nissan Chemical Ind Ltd Method for converting sparingly water-soluble medical substance to amorphous state
US5968895A (en) * 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
FR2757397B1 (fr) * 1996-12-23 1999-03-05 Mazal Pharma Composition pharmaceutique a base de rheine ou de diacerheine a biodisponibilite amelioree
US6046177A (en) * 1997-05-05 2000-04-04 Cydex, Inc. Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
IT1292588B1 (it) * 1997-05-28 1999-02-08 Saitec Srl Procedimento per preparare forme alimentari ad elevata resa di sapore e le forme alimentari cosi' ottenute.
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
FR2806307B1 (fr) * 2000-03-20 2002-11-15 Mane Fils V Preparation parfumee solide sous forme de microbilles et utilisation de ladite preparation
US7067116B1 (en) * 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
US7201891B1 (en) * 2000-05-19 2007-04-10 Otsuka Pharmaceutical Co., Ltd. Pharmaceutical preparation for the diagnosis of helicobacter pylori infection
SG98393A1 (en) 2000-05-19 2003-09-19 Inst Materials Research & Eng Injectable drug delivery systems with cyclodextrin-polymer based hydrogels
US20030099703A1 (en) * 2000-08-11 2003-05-29 Shigeru Aoki Drug-containing solid dispersion having improved solubility
DE10114245A1 (de) * 2001-03-22 2002-10-02 Heraeus Kulzer Gmbh & Co Kg Herstellung und Verwendung einer Antibiotikum-/Antibiotika-Zubereitung
BR0102252B1 (pt) * 2001-04-10 2013-10-22 Sistema de liberação controlada para antagonista do receptor AT1 da angiotensina II, composição farmacêutica e seu uso
BR0210867A (pt) * 2001-07-06 2004-06-29 Lifecycle Pharma As Processo para a preparação de um material particulado, métodos para aglomeração controlada de um material sólido finamente disperso, para melhorar a biodisponibilidade de uma substância terapêutica e/ou profilaticamente ativa, e para melhorar a vida em prateleira de uma composição farmacêutica, material articulado, composição farmacêutica, uso de um veìculo, material particulado farmacêutico, e, uso de aluminossilicato de magnésio e/ou de aluminometassilicato de magnésio
IS6390A (is) * 2001-08-31 2003-03-03 Heraeus Kulzer Gmbh & Co. Kg Reynsla af sýklalyfjahúðun skrokka sem í eru örholrými, þannig húðuðum skrokkum og einnig af notkunþeirra
ITBO20020094A1 (it) 2002-02-22 2003-08-22 Tecnea Engineering S R L Procedimento per la realizzazione di composizioni ed apparecchiatura realizzante tale procedimento
JP2005298338A (ja) * 2002-02-27 2005-10-27 Eisai Co Ltd 速崩壊性圧縮成形製剤
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
CA2489295A1 (en) * 2002-06-27 2004-01-08 Cilag Ag Spherical pellet containing a water-soluble active ingredient
DE10247037A1 (de) * 2002-10-09 2004-04-22 Abbott Gmbh & Co. Kg Herstellung von festen Dosierungsformen unter Verwendung eines vernetzten nichtthermoplastischen Trägers
DE10315640A1 (de) * 2003-04-04 2004-10-14 Ignatov, Konstantin Verfahren zur kontrollierten Freisetzung von Komponenten in eine Lösung
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE102004032051A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE502004008834D1 (de) * 2003-09-03 2009-02-26 Pharmaton Sa Kapseln enthaltend wirkstoffpellets mit unterschiedlichen freisetzungsprofilen
WO2005049306A1 (en) * 2003-11-18 2005-06-02 Eurand Pharmaceuticals Limited Ultrasound-assisted compaction process with a compaction device made of coupled plastic-metal materials
US20050196354A1 (en) * 2004-03-03 2005-09-08 Andre Soshinsky Film compositions
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
KR100760430B1 (ko) * 2004-12-31 2007-10-04 한미약품 주식회사 당뇨병 치료제의 경구 투여용 서방성 복합 제제 및 이의제조 방법
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102005024171A1 (de) * 2005-03-22 2006-09-28 Grünenthal GmbH Verfahren und Vorrichtung zur Ultraschallverpressung einer Tablette oder einer multipartikulären Arzneiform
RU2308915C2 (ru) * 2005-10-31 2007-10-27 Александр Николаевич Епихин Способ разрушения и удаления внутренних сред глаза - высокоскоростная механогидроэмульгация
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
EP2131816A1 (de) * 2007-03-08 2009-12-16 Smithkline Beecham Corporation Vorrichtung und verfahren für pharmazeutische analyse
RU2343886C1 (ru) * 2007-03-19 2009-01-20 Александр Николаевич Епихин Способ выбора параметров гидродинамического воздействия, используемого для разрушения хрусталика глаза
RU2351352C2 (ru) * 2007-04-09 2009-04-10 Закрытое акционерное общество "Санкт-Петербургский институт фармации" Твердая нанокомпозиция для доставки биологически активных веществ
JP5774853B2 (ja) 2008-01-25 2015-09-09 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 医薬投薬形
MX2010012039A (es) 2008-05-09 2010-11-30 Gruenenthal Gmbh Proceso para la preparacion de una formulacion de polvo intermedia y una forma de dosificacion solida final bajo el uso de un paso de congelacion por rocio.
TWI473610B (zh) * 2008-10-28 2015-02-21 Twi Biotechnology Inc 包含雙醋瑞因（ｄｉａｃｅｒｅｉｎ）之醫藥組合物
BR112012001547A2 (pt) 2009-07-22 2016-03-08 Gruenenthal Gmbh forma de dosagem farmacêutica extrusada por fusão a quente
ES2428938T3 (es) 2009-07-22 2013-11-12 Grünenthal GmbH Forma de dosificación resistente a la manipulación y estabilizada frente a la oxidación
CN103179954A (zh) 2010-09-02 2013-06-26 格吕伦塔尔有限公司 包含阴离子聚合物的抗破碎剂型
CA2808219C (en) 2010-09-02 2019-05-14 Gruenenthal Gmbh Tamper resistant dosage form comprising inorganic salt
CA2839123A1 (en) 2011-07-29 2013-02-07 Grunenthal Gmbh Tamper-resistant tablet providing immediate drug release
PL2736497T3 (pl) 2011-07-29 2018-01-31 Gruenenthal Gmbh Tabletka odporna na ingerencję, zapewniająca natychmiastowe uwalnianie leku
MX356421B (es) 2012-02-28 2018-05-29 Gruenenthal Gmbh Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico.
PL2838512T3 (pl) 2012-04-18 2018-12-31 Grünenthal GmbH Farmaceutyczna postać dawkowania odporna na niewłaściwe użycie i odporna na uderzeniowe uwalnianie dawki
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
WO2014191396A1 (en) 2013-05-29 2014-12-04 Grünenthal GmbH Tamper resistant dosage form with bimodal release profile
MX371432B (es) 2013-05-29 2020-01-30 Gruenenthal Gmbh Forma de dosificacion resistente al uso indebido que contiene una o mas particulas.
US10624862B2 (en) 2013-07-12 2020-04-21 Grünenthal GmbH Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
WO2015042461A1 (en) 2013-09-19 2015-03-26 Microvention, Inc. Polymer particles
CA2923741C (en) 2013-09-19 2022-06-07 Microvention, Inc. Polymer films
WO2015070094A1 (en) 2013-11-08 2015-05-14 Microvention, Inc. Polymer particles
WO2015078891A1 (en) 2013-11-26 2015-06-04 Farmaceutici Formenti S.P.A. Preparation of a powdery pharmaceutical composition by means of cryo-milling
US20150320690A1 (en) 2014-05-12 2015-11-12 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
EP3148512A1 (de) 2014-05-26 2017-04-05 Grünenthal GmbH Gegen entsorgung von ethanolischer dosis gesicherte mehrfachpartikel
WO2016154592A1 (en) 2015-03-26 2016-09-29 Microvention, Inc. Embiolic particles
BR112017021475A2 (pt) 2015-04-24 2018-07-10 Gruenenthal Gmbh forma de dosagem resistente à adulteração (tamper) com liberação imediata e resistência contra extração de solvente
AU2016319203A1 (en) 2015-09-10 2018-02-22 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations
CN109789222B (zh) 2016-09-28 2022-02-25 泰尔茂株式会社 聚合物颗粒

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2828206A (en) * 1954-02-24 1958-03-25 Roseuberg Adolf Stabilized fat-soluble vitamins and methods of making same
US3078216A (en) * 1961-04-11 1963-02-19 American Cyanamid Co Prolonged release oral pharmaceutical preparations
US3137630A (en) * 1961-06-09 1964-06-16 Eastman Kodak Co Process for preparing a dry, finely divided, gelatin particle product
US3146167A (en) * 1961-10-05 1964-08-25 Smith Kline French Lab Method of preparing sustained release pellets and products thereof
BE644643A (de) * 1963-03-04 1964-09-03
US3432593A (en) * 1963-09-18 1969-03-11 Key Pharm Inc Delayed and sustained release type pharmaceutical preparation
US3492397A (en) * 1967-04-07 1970-01-27 Warner Lambert Pharmaceutical Sustained release dosage in the pellet form and process thereof
US3822252A (en) * 1968-06-28 1974-07-02 Schering Corp 3-azetidinols
NL149711B (nl) * 1970-06-15 1976-06-15 Sumitomo Chemical Co Werkwijze voor het vervaardigen van pillen, alsmede de aldus vervaardigde pillen.
US3922339A (en) * 1974-06-20 1975-11-25 Kv Pharm Co Sustained release medicant
SE418247B (sv) * 1975-11-17 1981-05-18 Haessle Ab Sett att framstella kroppar med reglerad frigoring av en aktiv komponent
DE2904310A1 (de) * 1979-02-05 1980-08-07 Boehringer Mannheim Gmbh Formlinge mit retardierter wirkstofffreisetzung und verfahren zu deren herstellung
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
JPS58172311A (ja) * 1982-04-02 1983-10-11 Kodama Kk 持続性製剤及びその製法
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
PH18946A (en) * 1983-04-21 1985-11-14 Elan Corp Plc Controlled absorption pharmaceutical composition
JPS6094403A (ja) * 1983-10-27 1985-05-27 Nippon Sangaria Bebaretsuji Co:Kk 超音波を利用した粉末製剤の製造方法
US4779806A (en) * 1984-07-23 1988-10-25 Massachusetts Institute Of Technology Ultrasonically modulated polymeric devices for delivering compositions
US4657543A (en) * 1984-07-23 1987-04-14 Massachusetts Institute Of Technology Ultrasonically modulated polymeric devices for delivering compositions
JPS649932A (en) * 1987-07-01 1989-01-13 Toyo Capsel Kk Soft capsule preparation using newly combined component as the base
ES2073507T3 (es) * 1989-04-12 1995-08-16 Procter & Gamble Composiciones de productos solidos de consumo que contienen complejos con ciclodextrina en forma de pequeñas particulas.
JP2958103B2 (ja) * 1989-12-12 1999-10-06 エーザイ株式会社 プラズマ照射固形製剤
JPH03287544A (ja) * 1990-04-05 1991-12-18 Biomaterial Universe Kk 生体分解吸収性高分子材料を用いた徐放性薬剤
FR2664851B1 (fr) * 1990-07-20 1992-10-16 Oreal Procede de compactage d'un melange pulverulent permettant d'obtenir un produit compact absorbant ou partiellement delitable et produit obtenu par ce procede.
DE4031881C2 (de) * 1990-10-08 1994-02-24 Sanol Arznei Schwarz Gmbh Lösungsmittelfreie, oral zu verabreichende pharmazeutische Zubereitung mit verzögerter Wirkstoffreisetzung und Verfahren zu deren Herstellung

Also Published As

Publication number Publication date
RU2128499C1 (ru) 1999-04-10
DK0675710T3 (da) 2000-03-27
EP0675710A1 (de) 1995-10-11
DE69326163D1 (de) 1999-09-30
GR3031936T3 (en) 2000-03-31
EP0675710B1 (de) 1999-08-25
ES2138070T3 (es) 2000-01-01
WO1994014421A3 (en) 1994-08-18
JPH08504807A (ja) 1996-05-28
DE69326163T2 (de) 2000-05-04
KR100297541B1 (ko) 2001-11-26
WO1994014421A2 (en) 1994-07-07
CA2151396A1 (en) 1994-07-07
BR9307736A (pt) 1999-08-31
CA2151396C (en) 2006-08-22
KR960700043A (ko) 1996-01-19
JP3459421B2 (ja) 2003-10-20
AU6043494A (en) 1994-07-19
US5662935A (en) 1997-09-02
AU683044B2 (en) 1997-10-30

Similar Documents

Publication Publication Date Title
ATE183641T1 (de) Verfahren zur herstellung von arzneiformen und kontrollierte freigabe und die soerhaltenen arzneiformen
ATE147261T1 (de) Verfahren zur herstellung von tabletten mit hoher festigkeit
PL315181A1 (en) Method of producing pharmaceutical doses of hydrophobous substances in solid form
ATE129406T1 (de) Rotogranulate und geschmacksabdeckende überzüge zur herstellung pharmazeutischer kautabletten.
ATE101340T1 (de) Neue arzneimittelformulierung sowie verfahren zu deren herstellung.
ATE23110T1 (de) Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung.
NO960067L (no) Nytt farmasöytisk preparat
ATE136459T1 (de) Verfahren zur herstellung retardierter arzneimittelzubereitungen
HU9501953D0 (en) Pharmaceutically active pyridine derivatives and process for the preparation thereof
NO971965D0 (no) Farmasöytisk preparat inneholdende en smeltbar bærer og fremgangsmåte for fremstilling derav
DE69936430D1 (de) Verfahren zur Herstellung von in der Mundhöhle rasch zerfallenden Tabletten
ATE213164T1 (de) Verwendung von nona- und dekapeptiden zur herstellung eines arzneimittels zur bekämpfung von aids
HUT63954A (en) Process for producing active ingredient containing microparticldes from hydrolytically degredable polymers
ATE94410T1 (de) Verfahren zur herstellung einer festen form mit beibehaltender freisetzung aus einer funktionellen aktiven komposition und die bei dem verfahren erhaltene dosierungsform.
IL112802A0 (en) Film coated tablets of paracetamol and domperidone and their preparation
HUT59319A (en) Pharmaceutical compositions with controlled release of active ingredient and process for producing same
ATE59960T1 (de) Theophyllintabletten mit verzoegerter freigabe.
DE69433012D1 (de) Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenac
HUT34344A (en) Process for producing tablets controlled dissolution of active ingredients
ATE202700T1 (de) Verfahren zur herstellung einer clodronat- zubereitung
DE59005781D1 (de) Verfahren zur herstellung geformter, verpresster dosiseinheiten mit retardierter freisetzung und entsprechende dosiseinheit.
AT399504B (de) Neue aminopropoxyimino-cycloalkanderivate, deren herstellung, arzneimittel, die diese verbindungen als wirkstoff enthalten sowie verfahren zur herstellung derselben
HUT53891A (en) Nematocide insecticide and acaricide comprising 5-substituted-3-arylisoxazole derivatives as active ingredient and process for producing the active ingredients
DE68915750D1 (de) Kathecholverbindungen, verfahren zur herstellung und arzneimittelzubereitung, die diese enthält.
KR790000794B1 (en) Process for preparing solid medicament

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee